These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9364698)

  • 21. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
    Schwendinger MG; O'Rourke M; Traweger A; Savidis-Dacho H; Pilz A; Portsmouth D; Livey I; Barrett PN; Crowe BA
    PLoS One; 2013; 8(11):e79022. PubMed ID: 24260146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans.
    Fingerle V; Liegl G; Munderloh U; Wilske B
    Med Microbiol Immunol; 1998 Oct; 187(2):121-6. PubMed ID: 9832327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
    Stover CK; Bansal GP; Hanson MS; Burlein JE; Palaszynski SR; Young JF; Koenig S; Young DB; Sadziene A; Barbour AG
    J Exp Med; 1993 Jul; 178(1):197-209. PubMed ID: 8315378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.
    Voordouw MJ; Tupper H; Önder Ö; Devevey G; Graves CJ; Kemps BD; Brisson D
    Vector Borne Zoonotic Dis; 2013 Apr; 13(4):203-14. PubMed ID: 23428088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of outer surface protein A by Borrelia burgdorferi during transmission from infected mammals to feeding ticks is insufficient to trigger OspA seroconversion.
    Woodman ME; Cooley AE; Stevenson B
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):277-82. PubMed ID: 18793197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against Lyme disease: past, present, and future.
    Embers ME; Narasimhan S
    Front Cell Infect Microbiol; 2013; 3():6. PubMed ID: 23407755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.
    Gipson CL; de Silva AM
    Infect Immun; 2005 Mar; 73(3):1644-7. PubMed ID: 15731064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
    Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rodent species as natural reservoirs of Borrelia burgdorferi sensu lato in different habitats of Ixodes ricinus in The Netherlands.
    Gassner F; Takken W; Plas CL; Kastelein P; Hoetmer AJ; Holdinga M; van Overbeek LS
    Ticks Tick Borne Dis; 2013 Sep; 4(5):452-8. PubMed ID: 23891104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B; Freer H; Rollins A; Erb HN
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.
    Straubinger RK; Chang YF; Jacobson RH; Appel MJ
    J Clin Microbiol; 1995 Oct; 33(10):2745-51. PubMed ID: 8567917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apodemus species mice are reservoir hosts of Borrelia garinii OspA serotype 4 in Switzerland.
    Huegli D; Hu CM; Humair PF; Wilske B; Gern L
    J Clin Microbiol; 2002 Dec; 40(12):4735-7. PubMed ID: 12454181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.
    Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH
    Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative incompetence of european rabbits for Lyme disease spirochaetes.
    Matuschka FR; Schinkel TW; Klug B; Spielman A; Richter D
    Parasitology; 2000 Sep; 121 ( Pt 3)():297-302. PubMed ID: 11085249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.